Impact of pretreatment hematologic profile on survival of colorectal cancer patients

Tumor Biology

Volumn 31, Issue 4, 2010, Pages 255-260

  Qiu, Miao Zhen ^a   Yuan, Zhong Yu ^a   Luo, Hui Yan ^a   Ruan, Dan Yun ^a   Wang, Zhi Qiang ^a   Wang, Feng Hua ^a   Li, Yu Hong ^a   Xu, Rui Hua ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

Anemia; Colorectal cancer; Leukocytosis; Thrombocytosis

Indexed keywords

HEMOGLOBIN;

ADULT; ADVANCED CANCER; AGE; AGED; ANEMIA; ARTICLE; CANCER GRADING; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HUMAN; LEUKOCYTOSIS; LYMPH VESSEL; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; SEX DIFFERENCE; SURVIVAL TIME; THROMBOCYTOSIS; TUMOR LOCALIZATION; ADOLESCENT; COLORECTAL TUMOR; MIDDLE AGED; MORTALITY; PATHOLOGY; RETROSPECTIVE STUDY; SURVIVAL RATE; THROMBOCYTE COUNT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANEMIA; COLORECTAL NEOPLASMS; FEMALE; HUMANS; LEUKOCYTOSIS; MALE; MIDDLE AGED; PLATELET COUNT; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; THROMBOCYTOSIS; YOUNG ADULT;

EID: 77954629839     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-010-0024-x     Document Type: Article

References (28)

1. Chen MH, Chang PM, Chen PM, Tzeng CH, Chu PY, Chang SY, et al. Prognostic significance of a pretreatment hematologic profile in patients with head and neck cancer. J Cancer Res Clin Oncol. 2009;135:1783-90.
2. Caro JJ, Salas M, Ward A, Goss G. Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review. Cancer. 2001;91:2214-21.
3. Dunst J, Kuhnt T, Strauss HG, Krause U, Pelz T, Koelbl H, et al. Anemia in cervical cancers: impact on survival, patterns of relapse, and association with hypoxia and angiogenesis. Int J Radiat Oncol Biol Phys. 2003;56:778-87.
4. Baghi M, Wagenblast J, Hambek M, Moertel S, Gstoettner W, Strebhardt K, et al. Pre-treatment haemoglobin level predicts response and survival after TPF induction polychemotherapy in advanced head and neck cancer patients. Clin Otolaryngol. 2008;33:245-51.
5. Rades D, Schild SE, Bahrehmand R, Zschenker O, Alberti WA, Rudat VR. Prognostic factors in the nonsurgical treatment of esophageal carcinoma with radiotherapy or radiochemotherapy: the importance of pretreatment hemoglobin levels. Cancer. 2005;103:1740-6.
6. Pedersen LM, Milman N. Prognostic significance of thrombocytosis in patients with primary lung cancer. Eur Respir J. 1996;9:1826-30.
7. Costantini V, Zacharski LR, Moritz TE, Edwards RL. The platelet count in carcinoma of the lung and colon. Thromb Haemost. 1990;64:501-5.
8. Ikeda M, Furukawa H, Imamura H, Shimizu J, Ishida H, Masutani S, et al. Poor prognosis associated with thrombocytosis in patients with gastric cancer. Ann Surg Oncol. 2002;9:287-91.
9. Monreal M, Fernandez-Llamazares J, Piñol M, Julian JF, Broggi M, Escola D, et al. Platelet count and survival in patients with colorectal cancer-a preliminary study. Thromb Haemost. 1998;79:916-8.
10. Shimada H, Oohira G, Okazumi S, Matsubara H, Nabeya Y, Hayashi H, et al. Thrombocytosis associated with poor prognosis in patients with esophageal carcinoma. J Am Coll Surg. 2004;198:737-41.
11. Chen CC, Chang JY, Liu KJ, Chan C, Ho CH, Lee SC, et al. Hepatocellular carcinoma associated with acquired von Willebrand disease and extreme thrombocytosis. Ann Oncol. 2005;16:988-9.
12. Suzuki K, Aiura K, Kitagou M, Hoshimoto S, Takahashi S, Ueda M, et al. Platelets counts closely correlate with the disease-free survival interval of pancreatic cancer patients. Hepatogastroenterology. 2004;51:847-53.
13. BrockmannMA, Giese A,Mueller K, Mueller K, Kaba FJ, Lohr F, et al. Preoperative thrombocytosis predicts poor survival in patients with glioblastoma. Neurooncol. 2007;9:335-42.
14. Gogus C, Baltaci S, Filiz E, Elhan A, Bedük Y. Significance of thrombocytosis for determining prognosis in patients with localized renal cell carcinoma. Urology. 2004;63:447-50.
15. Lu CC, Chang KW, Chou FC, Cheng CY, Liu CJ. Association of pretreatment thrombocytosis with disease progression and survival in oral squamous cell carcinoma. Oral Oncol. 2007;43:283-8.
16. Li AJ, Madden AC, Cass I, Leuchter RS, Lagasse LD, Karlan BY. The prognostic significance of thrombocytosis in epithelial ovarian carcinoma. Gynecol Oncol. 2004;92:211-4.
17. Taucher S, Salat A, Gnant M, Kwasny W, Mlineritsch B, Menzel RC, et al. Impact of pretreatment thrombocytosis on survival in primary breast cancer. Thromb Haemost. 2003;89:1098-106.
18. Hefler L, Mayerhofer K, Leibman B, Obermair A, Reinthaller A, Kainz C, et al. Tumor anemia and thrombocytosis in patients with vulvar cancer. Tumour Biol. 2000;21:309-14.
19. Kasuga I, Makino S, Kiyokawa H, Katoh H, Ebihara Y, Ohyashiki K. Tumor-related leukocytosis is linked with poor prognosis in patients with lung carcinoma. Cancer. 2001;92:2399-405.
20. Bruckner HW, Lavin PT, Plaxe SC, Storch JA, Livstone EM. Absolute granulocyte, lymphocyte, and monocyte counts. Useful determinants of prognosis for patients with metastatic cancer of the stomach. J Am Med Assoc. 1982;247:1004-6.
21. Mroczko B, Groblewska M, Wereszczynska-Siemiatkowska U, Okulczyk B, Laszewicz W, Dabrowski A, et al. Serum macrophage-colony stimulating factor levels in colorectal cancer patients correlate with lymph node metastasis and poor prognosis. Clin Chim Acta. 2007;380:208-12.
22. Tesarova P, Kvasnicka J. Erythropoietin therapy in cancer patients. Cas Leuk Ces. 1995;20:647-50.
23. DeRienzo DP, Saleem A. Anaemia of chronic disease: a review of pathogenesis. Texas Med. 1990;86:80-3.
24. Ludwig H, Fritz E. Anemia in cancer patients. Semin Oncol. 1998;25 Suppl 7:2-6.
25. Yang MH, Wu MZ, Chiou SH, Chen PM, Chang SY, Liu CJ, et al. Direct regulation of TWIST by HIF-1alpha promotes metastasis. Nat Cell Biol. 2008;10:295-305.
26. Patruno R,ArpaiaN, Gadaleta CD, Passantino L, Zizzo N,Misino A, et al. VEGF concentration from plasma activated platelets rich correlates with microvascular density and grading in canine mast cell tumour spontaneous model. J Cell Mol Med. 2008;13:555-61.
27. Gunsilius E, Petzer A, Stockhammer G,NussbaumerW, Schumacher P, Clausen J, et al. Thrombocytes are the major source for soluble vascular endothelial growth factor in peripheral blood. Oncology. 2000;58:169-74.
28. Peduzzi P, Concato J, Kemper E, Holford TR, Feinstem AR. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol. 1996;49:1373-9.